Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that clinically vulnerable and clinically extremely vulnerable people are provided adequate information in respect of covid-19 booster vaccinations.

NHS England and NHS Improvement are in regular contact with groups representing people in at risk groups to provide the latest information on booster vaccinations. The current guidance is available at the following link:

https://www.nhs.uk/conditions/coronavirus-covid-19/people-at-higher-risk/who-is-at-high-risk-from-coronavirus/

NHS England and NHS Improvement also provide information directly to National Health Service systems and general practitioner practices in particular. On 4 January 2022, a letter was sent to NHS systems highlighting new guidance for people whose immune system means they are at higher risk of serious illness if they become infected with COVID-19. The letter is available at the following link:

https://www.england.nhs.uk/coronavirus/publication/information-on-the-governments-additional-covid-19-advice-for-people-whose-immune-system-means-they-are-at-higher-risk/

Those in at-risk groups are also featured in targeted advertising campaigns for the vaccination programme. This is supported by a large-scale marketing campaign, including TV, radio, press partnerships, social media and digital/social media takeovers. There is also ongoing engagement with stakeholders, community groups and faith leaders to reinforce the vaccine messaging among ethnic minority communities, patient groups and disproportionately impacted communities.